Patients’ subjective assessment as a decisive predictor of malignancy in pelvic masses: results of a multicentric, prospective pelvic mass study

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
   PubMed Web of Science ®Google Scholar
• Hennessy B, Coleman R, Markman M. Ovarian cancer. Lancet. 2009;374(9698):1371–1382.
   PubMed Web of Science ®Google Scholar
• Baldwin LA, Huang B, Miller RW, et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012;120(3):612–618.
   PubMed Web of Science ®Google Scholar
• Chekerov R, Hilpert F, Mahner S, et al. Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2018;19(9):1247–1258.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003;3:502–516.
   PubMed Web of Science ®Google Scholar
• Du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe D’investigateurs Nationaux Pour Les Etudes Des Cancers De L’ovaire (GINECO). Cancer. 2009;115(6):1234–1244.
   PubMed Web of Science ®Google Scholar
• Du Bois A, Rochon J, Lamparter C, et al. Die Qualität der Therapie des Ovarialkarzinoms in Deutschland – Dritte Stufe der Qualitätssicherungserhebung QS-OVAR der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Kommission OVAR. Frauenarzt. 2009;50:742–751.
   Google Scholar
• Goff BA, Matthews BJ, Larson EH, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109(10):2031–2042.
   PubMed Web of Science ®Google Scholar
• Earle CC, Schrag D, Neville BA, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98(3):172–180.
   PubMedGoogle Scholar
• Gostout BS, Brewer MA. Guidelines for referral of the patient with an adnexal mass. Clin Obstet Gynecol. 2006;49(3):448–458.
   PubMed Web of Science ®Google Scholar
• Giede KC, Kieser K, Dodge J, et al. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol. 2005;99(2):447–461.
   PubMed Web of Science ®Google Scholar
• Braicu EI, Pietzner K, Henrich W, et al. Möglichkeiten und grenzen der diagnostik beim ovarialkarzinom. Onkologe. 2014;20(7):650–657.
   Google Scholar
• Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31(6):681–690.
   PubMed Web of Science ®Google Scholar
• Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005;23(34):8794–8801.
   PubMed Web of Science ®Google Scholar
• Bristow R, Zahurak M, Delcarmen M, et al. Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol Oncol. 2004;93(2):353–360.
   PubMed Web of Science ®Google Scholar
• McIntosh MW, Drescher C, Karlan B, et al. Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol. 2004;95(1):9–15.
   PubMed Web of Science ®Google Scholar
• Valentin L. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol. 1999;14(4):273–283.
   PubMed Web of Science ®Google Scholar
• Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol. 1996;103(8):826–831.
   PubMedGoogle Scholar
• Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10):922–929.
   PubMedGoogle Scholar
• Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer. 1993;71(2 Suppl.):517–523.
   PubMed Web of Science ®Google Scholar
• Fitch M, Deane K, Howell D, et al. Women's experiences with ovarian cancer: reflections on being diagnosed. Can Oncol Nurs J. 2002;12(3):152–159.
   PubMedGoogle Scholar
• Sharot T, Riccardi AM, Raio CM, et al. Neural mechanisms mediating optimism bias. Nature. 2007;450(7166):102–105.
   PubMed Web of Science ®Google Scholar
• Goff BA, Mandel LS, Melancon CH, et al. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. J Am Med Assoc. 2004;291:8.
   Web of Science ®Google Scholar
• Goff BA, Mandel L, Muntz HG, et al. Ovarian carcinoma diagnosis: results of a National Ovarian Cancer Survey. Cancer. 2000;89(10):2068–2075.
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Kornblith AB, Wong G, et al. Pain in ovarian cancer patients – prevalence, characteristics, and associated symptoms. Cancer. 1994;74(3):907–915.
   PubMed Web of Science ®Google Scholar
• Hamilton W, Peters TJ, Bankhead C, et al. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ. 2009;339:b2998.
   PubMed Web of Science ®Google Scholar
• Rufford B, Jacobs I, Menon U. Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG. 2006;114(1):59–64.
   Web of Science ®Google Scholar
• Smith LH, Morris CR, Yasmeen S, et al. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer. 2005;104(7):1398–1407.
   PubMed Web of Science ®Google Scholar
• Olson SH, Mignone L, Nakraseive C, et al. Symptoms of ovarian cancer. Obstet Gynecol. 2001;98:6.
   Google Scholar
• Shen-Gunther J, Mannel RS. Ascites as a predictor of ovarian malignancy. Gynecol Oncol. 2002;87(1):77–83.
   PubMed Web of Science ®Google Scholar
• Boll D, Geomini PMAJ, Brolmann HAM, et al. The pre-operative assessment of the adnexal mass: the accuracy of clinical estimates versus clinical prediction rules. BJOG. 2003;110(5):519–523.
   PubMed Web of Science ®Google Scholar